Kevin S. Blair - 16 Feb 2024 Form 4 Insider Report for SYNOVUS FINANCIAL CORP (SNV)

Role
President and CEO
Signature
/s/ Mary Maurice Young
Issuer symbol
SNV
Transactions as of
16 Feb 2024
Net transactions value
-$844,744
Form type
4
Filing time
21 Feb 2024, 16:32:55 UTC
Previous filing
20 Feb 2024
Next filing
22 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNV Common Stock Options Exercise $0 +9,243 +11% $0.000000 96,182 16 Feb 2024 Direct F1
transaction SNV Common Stock Disposed to Issuer $339,403 -9,243 -9.6% $36.72 86,939 16 Feb 2024 Direct F1
transaction SNV Common Stock Options Exercise $0 +6,612 +7.6% $0.000000 93,551 17 Feb 2024 Direct F1
transaction SNV Common Stock Disposed to Issuer $242,793 -6,612 -7.1% $36.72 86,939 17 Feb 2024 Direct F1
transaction SNV Common Stock Options Exercise $0 +7,150 +8.2% $0.000000 94,089 18 Feb 2024 Direct F1
transaction SNV Common Stock Disposed to Issuer $262,548 -7,150 -7.6% $36.72 86,939 18 Feb 2024 Direct F1
holding SNV Fixed/Floating Rate Non-Cum Perpetual Preferred Stock Ser D 2,000 16 Feb 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNV Restricted Stock Units Options Exercise $0 -9,243 -33% $0.000000 18,484 16 Feb 2024 Common Stock 9,243 Direct F1
transaction SNV Restricted Stock Units Options Exercise $0 -6,612 -50% $0.000000 6,612 17 Feb 2024 Common Stock 6,612 Direct F1
transaction SNV Restricted Stock Units Options Exercise $0 -7,150 -100% $0.000000* 0 18 Feb 2024 Common Stock 7,150 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are subject to restricted stock units that will be settled in cash upon vesting. The units vest 1/3 each year over a three-year period subject to the reporting person's continued employment with Synovus.